ATA former Secretary/COO Rick Kloos joins Veracyte as Senior Medical Director, Endocrinology

By April 10, 2012 August 8th, 2017 2012 News Releases, News Releases

Falls Church, Va. — April 10, 2012 — Former secretary/COO of the American Thyroid Association (ATA), Richard T. Kloos, M.D., has been appointed senior medical director of Veracyte, a molecular diagnostics company, where he will lead all thyroid product medical efforts. Dr. Kloos was Secretary/Chief Operating Officer of the American Thyroid Association (ATA) from 2007-2011, chaired the guidelines committee on Medullary Thyroid Cancer and was a member of the guidelines committee for Differentiated Thyroid Cancer  As Secretary/COO of the ATA he served as chairman of the ATA Board of Directors and on the ATA executive committee.

Dr. Kloos is currently a professor of medicine in the divisions of Endocrinology and Metabolism, and Nuclear Medicine at The Ohio State University (OSU) and attending physician at The OSU Comprehensive Cancer Center and co-director of The OSU Thyroid Cancer Unit.

Dr. Kloos remarked on the “value of active participation in the scientific and social life of the ATA.  Service to the ATA has allowed me to develop and demonstrate skills that translated into many settings and have benefited me in my daily life with patients, academics, and towards my new career direction in industry. I would highly recommend that others become passionately involved in their professional societies. I am grateful for the many opportunities that the ATA has given me, and I look forward to continuing my active ATA participation.”  


The American Thyroid Association (ATA) is the leading worldwide organization dedicated to the advancement, understanding, prevention, diagnosis and treatment of thyroid disorders and thyroid cancer. ATA is an international individual membership organization with over 1,600 members from 43 countries around the world. Celebrating its 89th anniversary, ATA delivers its mission through several key endeavors: the publication of highly regarded monthly journals, THYROID, Clinical Thyroidology and Clinical Thyroidology for Patients; annual scientific meetings; biennial clinical and research symposia; research grant programs for young investigators, support of online professional, public and patient educational programs; and the development of guidelines for clinical management of thyroid disease. Visit for more information.